Despite being rare, the incidence of pregnancy-related cancer is expected to rise as women continue to delay childbearing and give birth later in their reproductive years. In this broad category, tumors like breast cancer, dermatological neoplasia and cervical cancer are most common and tend to arise in women of childbearing age. All pregnant women with clinical and cytologic suspicion of cervical cancer, except for squamous atypia or low-grade squamous intraepithelial lesions, should undergo colposcopy, with or without biopsy, the latter being avoided if possible due to possible complications which, although rare, may involve preterm labor initiation.
Introduction
Although rare, the incidence of pregnancy-related cancer is expected to rise as women continue to delay childbearing and give birth later in their reproductive years (1) . For a cancer to be categorized as pregnancyassociated neoplasia, it must be diagnosed during pregnancy or up to 1 year after delivery. The incidence rate for this type of cancer ranges from 17 to 38 cases/100.000 births (2) (3) (4) .
Within this broad category, tumors like breast cancer, dermatological neoplasia and cervical cancer are most common and tend to arise in women of childbearing age. In fact, cervical cancer is the most frequently encountered gynecologic malignancy during the reproductive years (5), and its incidence has been steadily increasing over the past 2 decades (6).
Discussion

 Pregnancy-related cervical cancer diagnosis and treatment; Clinical symptoms
One major advantage is that due to the regular medical consultations associated with pregnancy, early detection is more likely (5) . However, on the down side, while the pregnant woman has the same clinical symptoms of cervix carcinoma as the non-pregnant one, some of these symptoms, such as vaginal bleeding especially after sexual intercourse, may be misinterpreted and misdiagnosed as pregnancy-related rather than cancer-related issues. Others like pelvic pain, symptoms that mimic urinary and large bowel diseases, or sciatic-like pain can be mistaken for complications of pregnancy, leading to diagnostic delay for cancer.
 Cytology
Because of these circumstances, a high index of suspicion is required to diagnose carcinoma cervix during pregnancy, with screening programs focused on clinical symptoms, along with PAP smears, implemented in order to obtain an early stage diagnosis. All pregnant woman with clinical and cytologic suspicion of cervical cancer, except for squamous atypia or low-grade squamous intraepithelial lesions, should undergo colposcopy, with or without biopsy, the latter avoided when possible due to possible (though rare) complications such as preterm childbirth initiation. One of the clinical pitfalls that may occur because of physiological cervical changes during pregnancy such as increased vascularity, hypertrophy and hyperplasia of the endocervical glands, is that of a CIN-like (cervical dysplasia) diagnosis. Progression of low-grade dysplasia to carcinoma during pregnancy is rare (7).
A biopsy-confirmed LSIL is to be followed Nevertheless, these examinations should be performed only when necessary and the dose should be as low as possible.
In order to standardize all external and internal dosages, a new generation of models is under development using standardized software for internal dose calculations based on the dose estimates for radiopharmaceuticals (12) .
 Positron emission tomography (PET-CT)
The fetal radiation dose from 18F-FDG PET studies is below the dose that can determine effects of radiation exposure to the fetus (13) . Nevertheless, this procedure is more sensitive and specific than other imaging tools and can be applied as a staging and restaging method to guide treatment.
 Additional imaging tools
As additional imaging tools, cystoscopy and sigmoidoscopy are also safe during pregnancy, and can contribute to a differential diagnosis as well as the diagnosis of some of the complications due to local extension of cervix neoplasia. 
Stages IB1 (tumor size >2 cm and higher stages)
Despite the similarity in oncological outcomes of VRT and ART, the results for this stage are less than optimal.
Neoadjuvant chemotherapy (NACT)
NACT should be avoided during the first trimester as this is the highest risk period for interfering with fetal development and causing birth defects. Therefore, thorough medical counseling and a careful choice of treatment is critical before commencing therapy (26) .
NACT is an option to keep the progression of the disease low, until fetal maturation, and should be followed by radical hysterectomy postpartum. Even with indications that NACT can improve oncological outcome, only a few clinical studies support this approach and it remains unclear if it offers a benefit over surgery alone (27) , considering that the physiological changes of pregnancy result in a decreased blood concentration of chemotherapeutic agents. Alternatively, postpartum cisplatin chemo-sensibilisation (after radical hysterectomy following cesarean and pelvic radiation) seems to be the path in the future (28) .
Nevertheless, NACT for the treatment of locally invasive cervical cancer during the 2nd and 3rd trimester of pregnancy, partially due to the fetal protection offered by the placental barrier-function, appears be a good option until fetal viability is obtained and a standard oncological treatment can be implement (29) . In the end, chemotherapy has only one major contraindication, namely, breastfeeding.
No matter which treatment path is chosen, thromboembolism prevention is critical as both cancer and pregnancy are risk factors.
 How and when should we deliver or terminate the pregnancy?
Vaginal birth has several advantages: less blood loss and fewer risks than operative delivery, shorter hospital stays, and more importantly, faster recovery in order to begin chemotherapy. Disadvantages may include trauma of the lower uterine section and possible wound metastasis. In contrast, if pregnancy is to be terminated, the best timing should balance the risks and benefits for the mother and fetus. In situations involving lifethreatening maternal disease, priority is given to maternal health management. Nevertheless, cancer treatment during pregnancy includes risks for the fetus.
Terminating the pregnancy earlier in order to enable standard oncological treatment includes risks as pregnancy loss or preterm childbirth.
Neonatal outcome
Despite the fact that most studies have revealed good results for the fetus on long term follow up, neonatal outcome depends upon the type of treatment and more importantly, the age of gestation when the patient undergoes treatment. Complications after treatment are: pregnancy progression arrested, low or mediocre Apgar score, and perinatal mortality. Nonetheless, there is always a high risk of prematurity (especially after chemotherapy), with major negative outcomes: fetal morbidity and mortality.
 Psychological aspects
During pregnancy, psychological resilience is elevated due to the fact that the mother is "fighting" for her child. After childbirth, it is often more difficult for the woman to deal with cancer diagnosis and treatment.
The combination of postpartum depressed mood to different degrees and sleep deprivation makes these patients extremely vulnerable. Thus it is important to discuss these issues with the patient before delivery and continue with psychological treatment after.
Counseling plays an important role and, due to the sensitivity of the issue, all options should be discussed with both mother and spouse/partner/father. .Extensive counseling regarding risks could improve both short and long term psychological outcomes (30) .
Conclusions
Because of the complexity surrounding pregnancy, a multidisciplinary team that includes gynecologist, medical and surgical oncologist and radiologist is required to establish the best way to diagnose and treat the disease. Both maternal and the fetal well-being should be considered when the medical team must choose between termination of pregnancy, delay of maternal treatment, or iatrogenic preterm delivery.
Psychological counseling plays an important role and due to the sensitivity of the issue, should continue through gestation and the postpartum.
In order to develop optimal guidelines for the diagnosis, treatment, and treatment efficacy, large prospective studies will be required, although due to the low prevalence of cervical cancer cases associated with pregnancy, carrying out such studies will present a challenge.
